SOX9 and Alzheimer disease: SOX9 was significantly upregulated [p<0.001 (p=1.48e-9)] in AD tissue compared to control with a median log2 expression of 9.86 (IQR 9.42-10.47) and median of 9.31 (IQR 9.67-9.90) respectively (Figure 1).